Most Recent
Construction PRO
Another fight over an $87 million mixed-use Canberra development may be on the cards, after the project's liquidators won approval to assign potential claims against WSP and builder Construction Control over alleged stitch bolt defects.
US lab products giant Beckman Coulter has successfully opposed an Australian biotech's bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman's ‘CytoFLEX’ mark.
Former Spotlight producer Taylor Auerbach has sued Seven over comments it made concerning his dealings with Bruce Lehrmann, after he gave "sordid" evidence in the defamation trial.
A lawyer accused of trying to blackmail personal injury firm Maliganis Edwards Johnson has won a challenge to an injunction, with a judge finding the blackmail allegation was more nuanced than conveyed by the Canberra firm.
Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis' appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.
The funder that backed a shareholder class action against engineering firm CIMIC that settled for $45.25 million will take a cut to its 25 per cent commission, but wants the court to find the commission would otherwise have been reasonable.
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
Construction PRO
Former directors of collapsed Sydney developer Dyldam have been targeted by a liquidator over claims allegedly worth at least $33 million.
Payday lender Sunshine Loans has lost an appeal after it was ruled liable for “wrongheaded” conduct, with an appeals court finding that counsel showed an “egregious failure” to confine the case to the real issues.
Fortrend Securities has appealed a finding that it breached the Fair Work Act in withholding the bonuses of two financial advisors who jumped to rival Shaw & Partners.